The world of clinical trials is changing. Digital technology has opened new possibilities for decentralised trials, which offer accelerated timelines, improved scalability and a more patient-centric approach compared to traditional processes centred around hospitals. But switching to this new model also comes with certain difficulties and challenges related to data security and ethical implications, among other things.
As industry and regulatory bodies strive to address these challenges, PwC offers an overview of all the hurdles to overcome and the opportunities to seize when implementing decentralised clinical trials.
Read our white paper ‘The Evolving Clinical Trial Ecosystem’ to make sure you are prepared for the jump into a new era of clinical trials.